Day1 Company Inc. (KOSDAQ:373160)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,470.00
-100.00 (-1.52%)
Last updated: Aug 8, 2025

Ligand Pharmaceuticals Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Debt / Equity Ratio
0.260.50-0.45-0.57-1.28-1.03
Upgrade
Debt / EBITDA Ratio
1.371.962.36---
Upgrade
Debt / FCF Ratio
5.914.611.27--0.97
Upgrade
Asset Turnover
-1.931.741.852.311.74
Upgrade
Inventory Turnover
-2.122.343.253.764.12
Upgrade
Quick Ratio
1.861.340.440.390.250.65
Upgrade
Current Ratio
2.021.630.530.490.440.76
Upgrade
Return on Assets (ROA)
--0.27%1.05%-11.48%-18.91%-6.21%
Upgrade
Return on Capital (ROIC)
0.18%-2.36%---266.36%-73.58%
Upgrade
Buyback Yield / Dilution
-45.39%-35.91%-3.21%-1.23%-4.01%-7.31%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.